These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 813525)

  • 1. Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin.
    Colman RW; Habal M; Hollenberg NK; Birtch AG; Busch GJ
    Am J Pathol; 1976 Jan; 82(1):25-42. PubMed ID: 813525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful short-term modification of hyperacute renal allograft rejection in the primate. Intrarenal effects of phenoxybenzamine and methylprednisolone combined with heparin.
    Busch GJ; Martins AC; Hollenberg NK; Moretz RC; Wilson RE; Colman RW
    Am J Pathol; 1976 Jan; 82(1):43-60. PubMed ID: 813526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.
    Busch GJ; Kobayashi K; Hollenberg NK; Birtch AG; Colman RW
    Am J Pathol; 1975 Jul; 80(1):1-20. PubMed ID: 1098475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primate model of hyperacute renal allograft rejection.
    Busch GJ; Martins AC; Hollenberg NK; Wilson RE; Colman RW
    Am J Pathol; 1975 Apr; 79(1):31-56. PubMed ID: 1092189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts.
    Azuma H; Tomita N; Kaneda Y; Koike H; Ogihara T; Katsuoka Y; Morishita R
    Gene Ther; 2003 Mar; 10(5):415-25. PubMed ID: 12601396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
    Ito S; Camussi G; Tetta C; Milgrom F; Andres G
    Lab Invest; 1984 Aug; 51(2):148-61. PubMed ID: 6379289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
    Aharoni R; Yussim A; Sela M; Arnon R
    Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors.
    Eason JD; Wee S; Kawai T; Hong HZ; Powelson JA; Widmer MB; Cosimi AB
    Transplantation; 1995 Jan; 59(2):300-5. PubMed ID: 7839455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperacute renal allograft rejection in presensitized monkeys.
    Kobayashi K; Hricko GM; Luki P; Hunsicker L; Patel R; Reisner GS; Birtch AG
    Surg Forum; 1971; 22():246-8. PubMed ID: 5001065
    [No Abstract]   [Full Text] [Related]  

  • 11. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
    Yang H; Chen G; Kanai N; Shum J; Garcia B; Huang X; Min W; Luo Y; Dutartre P; Zhong R
    Transplantation; 2003 Apr; 75(8):1166-71. PubMed ID: 12717197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of renal allograft rejection.
    Ratner LE; Hadley GA; Hanto DW; Mohanakumar T
    Arch Pathol Lab Med; 1991 Mar; 115(3):283-7. PubMed ID: 2001169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of local heparin infusion in a canine renal allograft model.
    Gruber SA; Cipolle RJ; Tzardis P; Skjei KL; Jossart G; Abed JF; Canafax DM; Burke BA; Matas AJ; Hrushesky WJ
    J Pharmacol Exp Ther; 1990 Feb; 252(2):733-8. PubMed ID: 2313597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [State of local renal hemostasis in experimental nephritis after the administration of heparin, antithrombin III and prodectin].
    Sokratov NV
    Urol Nefrol (Mosk); 1985; (3):62-6. PubMed ID: 2409652
    [No Abstract]   [Full Text] [Related]  

  • 18. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
    Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
    J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.